Vivos Therapeutics Inc

NASDAQ:VVOSUnited States

Vivos Therapeutics, Inc. is a medical technology company. The Company is focused on the development and commercialization of diagnostic and treatment modalities for patients with dentofacial abnormalities and/or patients with mild to moderate obstructive sleep apnea (OSA) and snoring in adults. The Company call its OSA treatment protocol as The Vivos Method. The Vivos Method is a non-invasive, non-surgical, non-pharmaceutical, multi-disciplinary treatment modality for the treatment of dentofacial abnormalities and/or mild to moderate OSA and snoring. The Company’s program is to train dentists and offer them other value-added services in connection with their ordering and use of the Vivos System for patients is called the Vivos Integrated Practice program. Its primary product is used in the Vivos System is the Mandibular Repositioning Nighttime Appliance (mRNA) appliance, a specifically designed, custom oral appliance.

Contact Information

Headquarters

7921 Southpark Plaza,, Suite 210LITTLETON, CO, United States 80120

Phone

---

Fax

302-655-5049

Executives

Chairman of the Board, Chief Executive Officer, Co-Founder

R. Kirk Huntsman

Chief Financial Officer

Bradford Amman

Independent Director

Ralph Green

Independent Director

Anja Krammer

Independent Director

Mark Lindsay